NATALIA VESTAL: Open Payments
NPI 1487311502 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 50 payments from 9 companies in 2025. Trend: 2023 $52 · 2024 $1,615 · 2025 $1,430
Food & beverage: $1,286Education: $144
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 9 | $415 |
| Astellas Pharma US Inc | 6 | $264 |
| Actelion Pharmaceuticals US, Inc. | 19 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $211 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| Mallinckrodt Hospital Products Inc. | 3 | $80 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Invivyd Inc | 1 | $20 |
Products named: UPTRAVI, Remodulin, OFEV, Cresemba, Orenitram, STEEN SOLUTION, WINREVAIR, PURIFIED CORTROPHIN GEL.
Industry payments across FL — which companies pay providers there.
